Compare SCTX & APXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SCTX | APXT |
|---|---|---|
| Founded | 2017 | 2025 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 536.5M | 461.0M |
| IPO Year | 2026 | 2025 |
| Metric | SCTX | APXT |
|---|---|---|
| Price | $17.20 | $10.14 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $57.00 | N/A |
| AVG Volume (30 Days) | ★ 271.3K | 165.8K |
| Earning Date | 09-02-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $17.31 | $9.87 |
| 52 Week High | $39.60 | $10.19 |
| Indicator | SCTX | APXT |
|---|---|---|
| Relative Strength Index (RSI) | 34.53 | 50.75 |
| Support Level | N/A | $10.12 |
| Resistance Level | $26.50 | $10.15 |
| Average True Range (ATR) | 3.71 | 0.01 |
| MACD | -1.36 | -0.00 |
| Stochastic Oscillator | 4.94 | 33.33 |
Scribe Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of in vivo CRISPR-based genetic medicines. Its research and development activities focus on cardiovascular and metabolic diseases, including atherosclerotic cardiovascular disease (ASCVD). The company's product pipeline includes STX-1150, a CRISPR-based product candidate that utilizes its ELXR epigenetic silencing technology.
Apex Treasury Corp is a blank check company established for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.